Estrogen receptor mutation study suggests potential treatments for endometrial cancers
Researchers at Huntsman Cancer Institute identified potential new treatment options for people with endometrial cancer. Endometrial cancer is the most common gynecological cancer and high levels of estrogen promote its development. The study, published in Molecular Cancer Research discovered that estrogen receptor mutations found in endometrial cancers cause large changes in endometrial cancer cells.
Estrogen is a reproductive hormone that binds and activates estrogen receptors. Cancer can cause estrogen receptors to remain in a state of constant activity. That increases shedding of the endometrial ...











